Ribavirin FDA Approved Drugs
REBETOL [RibavirinC8H12N4O5]
RX
- 200mg (oral capsule)
40mg/ml (oral solution)
Merck Sharp DohmeJul 25, 2001
ScheringJul 29, 2003
ScheringJul 29, 2003
- Method of treating hepatitis c viral infection by continuous parenteral admin interferon alpha 2-10 million iu weekly, subcutaneously, injection of polymer-interferon alpha conjugate-polymer is peg-interferon is alpha 2b.
- Method of treating pt with chronic hepatitis c having hcv genotype 1 and viral load greater than 2 million copies/ml to eradicate detectable hcv-rna by admin combination of ribavirin and interferon alfa-2b for a least 24 weeks.
- Method of tx a pt suspected of having hepatitis c by admin, in combination, a conjugate comprising peg 12000 & interferon alfa-2b in an amt of from 0.5mcg/kg to 2mcg/kg, once weekly, and ribavirin.
- Method of using peg-intron/rebetol combination therapy and intron/rebetol combination therapy.
- Method of using rebetol capsules in combination with a conjugate comprising polyethylene glycol(peg) and an alpha interferon, including, for example, peg-intron powder for injection.
- Method of using ribavirin in combination with interferon alpha-2b(pegylated and nonpegylated) to treat patients with chronic hepatitis c.
- Method of using ribavirin in combination with pegylated interferon alpha-2b to treat patients with chronic hepatitis c.
RIBAVIRIN [RibavirinC8H12N4O5]
RX
- 200mg (oral tablet)
400mg (oral tablet)
500mg (oral tablet)
600mg (oral tablet)
6gm/vial (inhalation for solution)
Aurobindo PharmaSep 17, 2009
Kadmon Pharms LlcDec 5, 2005
SandozApr 6, 2004
Sandoz IncAug 12, 2014
TevaDec 5, 2005
Zydus Pharms UsaDec 5, 2005
Navinta LlcOct 6, 2016
Kadmon Pharms LlcDec 5, 2005
SandozApr 6, 2004
Sandoz IncAug 12, 2014
TevaDec 5, 2005
Zydus Pharms UsaDec 5, 2005
Navinta LlcOct 6, 2016
SOVALDI [SofosbuvirC22H29FN3O9P]
RX
- 400mg (oral tablet)
Gilead Sciences IncDec 6, 2013
- For the treatment of genotype 1, 2, 3 or 4 chronic hepatitis c virus (hcv) infection as a component of a combination antiviral treatment regimen with ribavirin.
- For the treatment of hepatitis c.
VIEKIRA PAK (COPACKAGED) [Dasabuvir Sodium : OmbitasvirC50H67N7O8 : ParitaprevirC40H43N7O7S : RitonavirC37H48N6O5S2]
RX
- eq 250mg base,n/a,n/a,n/a : n/a,12.5mg,75mg,50mg (oral tablet, tablet)
Abbvie IncDec 19, 2014
- Treatment of hcv infection using dasabuvir.
- Treatment of hcv infection using ombitasvir.
- Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir with ribavirin..
- Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir, without ribavirin.
- Treatment of hcv infection using paritaprevir.
- Use of dasabuvir to inhibit viral replication for the treatment of hcv infection..
VIEKIRA XR [Dasabuvir Sodium : OmbitasvirC50H67N7O8 : ParitaprevirC40H43N7O7S : RitonavirC37H48N6O5S2]
RX
- eq 200mg base : 8.33mg : 50mg : 33.33mg (oral tablet, extended release)
Abbvie IncJul 22, 2016
- Treatment of hcv infection using dasabuvir.
- Treatment of hcv infection using dasabuvir/ombitasvir/paritaprevir/ritonavir fixed dose combination.
- Treatment of hcv infection using ombitasvir.
- Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir with ribavirin..
- Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir, without ribavirin.
- Treatment of hcv infection using paritaprevir.
- Use of dasabuvir to inhibit viral replication for the treatment of hcv infection..
VIRAZOLE [RibavirinC8H12N4O5]
RX
- 6gm/vial (inhalation for solution)
Valeant Pharm IntlDec 31, 1985
- Use of ribavirin to increase type 1 cytokine response and suppress type 2 cytokine resp0nse to lymphocytes, including methods that take advantage of such modulation to treat infections and infestations.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.